Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients
Clinical trial NCT05823701 · UNKNOWN
Trial details
- NCT number
- NCT05823701
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2023-12-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.